Effects of resveratrol on the autophosphorylation of phorbol ester- responsive protein kinases: Inhibition of protein kinase D but not protein kinase C isozyme autophosphorylation

Biochemical Pharmacology

Volumn 60, Issue 9, 2000, Pages 1355-1359

  Stewart, Jubilee R ^a   Christman, Karen L ^a   O’Brian, Catherine A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cancer chemoprevention; Phorbol ester; Protein kinase C; Protein kinase D; Resveratrol; Tumor promotion

Indexed keywords

PHORBOL ESTER; PROTEIN KINASE C; RESVERATROL;

ARTICLE; AUTOPHOSPHORYLATION; CANCER PREVENTION; CHEMOPROPHYLAXIS; CONCENTRATION RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; IC 50; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; TUMOR PROMOTION;

ANTICARCINOGENIC AGENTS; CARCINOGENS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMAN; PEPTIDES; PHORBOL ESTERS; PHOSPHORYLATION; PROTEIN KINASE C; RECOMBINANT PROTEINS; STILBENES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0034333325     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(00)00450-0     Document Type: Article

References (22)

1. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W.W., Fong H.H.S., Farnsworth N.R., Kinghorn A.D., Mehta R.G., Moon R.C., Pezzuto J.M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 275:1997;218-220.
2. Jayatilake G.S., Jayasuriya H., Lee E.-S., Koonchanok N.M., Geahlen R.L., Ashendel C.L., McLaughlin J.L., Chang C.-J. Kinase inhibitors from Polygonum cuspidatum. J Nat Prod. 56:1993;1805-1810.
3. Subbaramaiah K., Chung W.J., Michaluart P., Telang N., Tanabe T., Inoue H., Jang M., Pezzuto J.M., Dannenberg A.J. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J Biol Chem. 273:1998;21875-21882.
4. Hsieh T.C., Wu J.M. Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer. Exp Cell Res. 249:1999;109-115.
5. Mitchell S.H., Zhu W., Young C.Y.F. Resveratrol inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells. Cancer Res. 59:1999;5892-5895.
6. Glazer R.I. The protein kinase ABC’s of signal transduction as targets for drug development. Curr Pharm Des. 4:1998;277-290.
7. Kuo JF (Ed.), Protein Kinase C. Oxford University Press, New York, 1994.
8. Van Lint J., Sinnett-Smith J., Rozengurt E. Expression and characterization of PKD, a phorbol ester and diacylglycerol-stimulated serine protein kinase. J Biol Chem. 270:1995;1455-1461.
9. Newton A.C. Regulation of protein kinase C. Curr Opin Cell Biol. 9:1997;161-167.
10. Stewart J.R., Ward N.E., Ioannides C.G., O’Brian C.A. Resveratrol preferentially inhibits protein kinase C-catalyzed phosphorylation of a cofactor-independent, arginine-rich protein substrate by a novel mechanism. Biochemistry. 38:1999;13244-13251.
11. Leventhal P.S., Bertics P.J. Activation of protein kinase C by selective binding of arginine-rich polypeptides. J Biol Chem. 268:1993;13906-13913.
12. Bruins R.H., Annable C., Ward N.E., Gravitt K.R., O’Brian C.A., Epand R.M. Evidence for a regulatory binding site for arginine-rich peptides on protein kinase C. Arch Biochem Biophys. 356:1998;258-264.
13. Matthews S.A., Rozengurt E., Cantrell D. Characterization of serine 916 as an in vivo autophosphorylation site for protein kinase D/protein kinase Cμ J Biol Chem. 274:1999;26543-26549.
14. Ward N.E., Pierce D.S., Stewart J.R., O’Brian C.A. A peptide substrate-based affinity label blocks protein kinase C-catalyzed ATP hydrolysis and peptide-substrate phosphorylation. Arch Biochem Biophys. 365:1999;248-253.
15. Feng X., Hannun Y.A. An essential role for autophosphorylation in the dissociation of activated protein kinase C from the plasma membrane. J Biol Chem. 273:1998;26870-26874.
16. Mellor H., Parker P.J. The extended protein kinase C superfamily. Biochem J. 332:1998;281-292.
17. Toullec D., Pianetti P., Coste H., Bellevergue P., Grand-Perret T., Ajakane M., Baudet V., Boissin P., Boursier E., Loriolle F., Duhamel L., Charon D., Kirilovsky J. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem. 266:1991;15771-15781.
18. Nixon J.S., Bishop J., Bradshaw D., Davis P.D., Hill C.H., Elliott L.H., Kumar H., Lawton G., Lewis E.J., Mulqueen M., Westmacott D., Wadsworth J., Wilkinson S.E. The design and biological properties of potent and selective inhibitors of protein kinase C. Biochem Soc Trans. 20:1992;419-425.
19. Zugaza J.L., Waldron R.T., Sinnett-Smith J., Rozengurt E. Bombesin, vasopressin, endothelin, bradykinin, and platelet-derived growth factor rapidly activate protein kinase D through a protein kinase C-dependent signal transduction pathway. J Biol Chem. 272:1997;23952-23960.
20. Chun Y.J., Kim M.Y., Guengerich F.P. Resveratrol is a selective human cytochrome P450 1A1 inhibitor. Biochem Biophys Res Commun. 262:1999;20-24.
21. Fontecave M., Lepoivre M., Elleingand E., Gerez C., Guittet O. Resveratrol, a remarkable inhibitor of ribonucleotide reductase. FEBS Lett. 421:1998;277-279.
22. Gehm B.D., McAndrews J.M., Chien P.Y., Jameson J.L. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci USA. 94:1997;14138-14143.